Consorci Sanitari de Terrassa

The trials here

What the 32 trials at this site are about, from their registry records.

Conditions

• Prostate cancer4 trials
• Asthma3 trials
• Childhood cancers2 trials
• Colorectal cancer2 trials
• Long COVID and ME/CFS2 trials
• Lung cancer2 trials
• Metastatic breast cancer2 trials
• Migraine2 trials
• Acute myeloid leukaemia1 trial
• Alzheimer disease1 trial
• Cervical cancer1 trial
• Chronic kidney disease1 trial
• and 8 more

Phase

• Phase 315 trials
• Phase 24 trials

Status

• Recruiting13 trials
• Active, not recruiting9 trials
• Completed8 trials
• Not yet recruiting2 trials

Lead sponsor

• Consorci Sanitari de Terrassa5 trials
• Hospital Universitari Vall d'Hebron Research Institute3 trials
• Fundación GECP2 trials
• LETI Pharma S.L.U.2 trials
• Merz Therapeutics GmbH2 trials
• and 18 more

Running trials

• Not yet recruiting

  Optimizing the Use of Aspirin for the Prevention of Preeclampsia

  NCT07665853· Phase 3· Hospital Universitari Vall d'Hebron Research Institute· Source

  Contact: Angels Vives

• Recruiting

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· Phase 3· LETI Pharma S.L.U.· Source

• Recruiting

  Grass Immunotherapy for Rhinitis and Asthma (GIRA)

  2025-521736-10-00· Phase 3· LETI Pharma S.L.U.· Source

• Recruiting

  A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s ineligible for standard induction chemotherapy

  2025-522979-29-00· Phase 3· Fundacion PETHEMA· Source

• Recruiting

  NOPE37: Angiogenic Factors for Managing Term Preeclampsia

  NCT07193680· Hospital Universitari Vall d'Hebron Research Institute· Source

  Contact: Esperanza Garcia

• Recruiting

  Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.

  2023-508547-51-00· Phase 3· Inmunotek S.L.· Source

• Active, not recruiting

  A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

  NCT07018713· Phase 3· Merz Therapeutics GmbH· Source

• Active, not recruiting

  A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

  NCT07018700· Phase 3· Merz Therapeutics GmbH· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  Chronic Insomnia in Non-Cancer Pain Patients

  NCT07057232· Germans Trias i Pujol Hospital· Source

  Contact: Antonio Montes Pérez, MD, PhD

• Recruiting

  Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

  NCT06431633· Phase 3· Fundación GECP· Source

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source

• Not yet recruiting

  Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler

  NCT05284474· Hospital Universitari Vall d'Hebron Research Institute· Source

  Contact: Angels Vives

• Recruiting

  Fractionated stereotactic radiotherapy plus second-generation antiandrogen for oligometastatic patients with castration-resistant prostate cancer. Phase II Spanish study, prospective, multicenter. (OLIGORESIST)

  2023-505024-62-01· Phase 2· Instituto de investigación en Oncología radioterápica FEOR (Fundación Española de Oncología RT)· Source

• Recruiting

  Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

  NCT07717268· Phase 2· Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic· Source

  Contact: Pablo Raña Diez, PhD

• Active, not recruiting

  Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial)

  NCT05817604· Consorci Sanitari de Terrassa· Source

• Recruiting

  The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer

  NCT05551416· EDUARDO ALBENIZ· Source

  Contact: Diana Zaffalon

• Active, not recruiting

  Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

  NCT04262609· Consorci Sanitari de Terrassa· Source

• Active, not recruiting

  TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation

  NCT03833479· Phase 2· Grupo Español de Investigación en Cáncer de Ovario· Source

• Active, not recruiting

  Clinical trial to compare the efficacy of two treatment sequencing schemes with chemotherapy (the regime called FOLFOX and FOLFIRI) in combination with biologic drugs (panitumumab and bevacizumab).

  NCT03635021· Phase 3· Asociacion Grupo Tratamiento De Tumores Digestivos· Source

• Recruiting

  Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer

  NCT03853733· Consorci Sanitari de Terrassa· Source

  Contact: Joan Lozano, MD

• Recruiting

  A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)

  NCT02819882· Spanish Breast Cancer Research Group· Source

  Contact: MS Study Project Manager

• Recruiting

  Thoracic Tumours Register

  NCT02941458· Spanish Lung Cancer Group· Source

  Contact: Remei Blanco, MD-PhD

• Active, not recruiting

  A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

  NCT01952223· Phase 3· UNICANCER· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma3 recruiting
• Acute myeloid leukaemia1 recruiting
• Alzheimer disease1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Macular degeneration1 recruiting
• Metastatic breast cancer1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  Long COVID-19 Intervention (COVIDL/MIQoL)

  NCT06492590· Consorci Sanitari de Terrassa· Source

• Completed

  Digital Multimodal Rehabilitation for People With Post-acute COVID-19 Syndrome.

  NCT05846126· Consorci Sanitari de Terrassa· Source

• Completed

  Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform

  NCT04823286· Cardenal Herrera University· Source

• Completed

  Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

  NCT06031038· Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa· Source

• Completed

  Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

  NCT03836066· Phase 2· Fundación GECP· Source

• Completed

  Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

  NCT03740165· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

  NCT03555422· Phase 3· Karyopharm Therapeutics Inc· Source

• Completed

  A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

  NCT01740427· Phase 3· Pfizer· Source